key: cord-0943539-ffqbijiq
authors: Angamuthu, Natarajan; Geraldine Gagasa, Emelia; Baker, Daryll; Tsui, Janice; Evan D’Souza, Rovan
title: Transmission of infection among health care personnel performing surgical tracheostomies on COVID-19 patients
date: 2021-02-12
journal: Surgeon
DOI: 10.1016/j.surge.2021.01.007
sha: 6215cec55689d2f45fa78e0868c94ddb58a94fe3
doc_id: 943539
cord_uid: ffqbijiq

Background Staff and patient safety are of paramount importance while performing a surgical tracheostomy(ST) during the corona virus disease(COVID-19) pandemic. The aim was to assess the incidence of COVID-19 infection among the healthcare personnel(HCP) performing ST on COVID-19 patients. Methods One hundred and twenty-two HCP participating in 71 ST procedures performed at our institution between 26th March 2020 and 27th May 2020 were identified. A COVID-19 health questionnaire was distributed among staff with their consent. Data related to the presence of COVID-19 symptoms(new onset continuous cough, fever, loss of taste and/or loss of smell) among HCP involved in ST as well as patient related data were collected. Results Of the HCP who responded, eleven(15%,11/72) reported key COVID-19 symptoms and went into self-isolation. Ten members from this group underwent a COVID-19 swab test and three tested positive. Only one HCP attended hospital for symptomatic treatment, none required hospitalisation. Sixty percent(43/72) of the responders had a COVID-19 antibody test with a positive rate of 18.6%(8/43). Among the patients undergoing a ST, 67%(37/55) required a direct intensive care unit(ICU) admission; the mean age was 58 years(29-78) with a male preponderance(65.5%). The median time from intubation to ST was 15 days (range 5-33,IQR=9). The overall mortality was 11%(6/55). Conclusions ST can be carried out safely with strict adherence to both, personnel protective equipment and ST protocols which are vital to mitigate the potential transmission of COVID-19 to the HCP.

Among the patients undergoing a ST, 67%(37/55) required a direct intensive care 23 unit(ICU) admission; the mean age was 58 years(29-78) with a male 24 preponderance(65.5%). The median time from intubation to ST was 15 days (range 25 5-33,IQR=9). The overall mortality was 11%(6/55). Novel corona virus disease (COVID-19) that originated in the Wuhan city, Hubei 37 province, China in December 2019 has evolved into a pandemic (1) . The infection 38 caused acute respiratory failure secondary to viral pneumonitis (1) . Another reason for 39 respiratory failure could be the higher occurrence of pulmonary embolism in COVID-40 19 patients when compared to pre-COVID patients(37%vs14.5%) (2) . About 20% of 41 those infected with the COVID-19 virus seem to need in-patient hospital admission 42 and a quarter of these needed intensive care admission (1) . Need for ventilation 43 varied from 42% to 100% (3, 4) . Many of these ventilated patients have required 44 tracheostomies to help easier management of the airway especially in those 45

There are numerous publications outlining the protocol for tracheostomy and head 48 and neck procedures in COVID-19 positive patients, mostly based on previous 49 experience with ST in severe acute respiratory syndrome (SARS) patients (1, (3) (4) (5) . We 50 adopted these recommendations and modified to suit our local needs (Appendix-1). 51

In a systematic review by Tran K et al, the odds ratio of an HCP developing an 52 infection when involved with tracheostomy procedure in patients with SARS was 4.2 53 (95% CI 1.5-11.5) (6) . 54 COVID-19 infection, predominantly an aerosol or droplet based respiratory 55 transmission, meant that PPE, risk stratification based on procedure type, and 56 compliance with donning and doffing would be vital to limit the spread to and among 57 healthcare providers (5, 6) . These along with re-organisation of the operating theatre 58 layout in the past during the SARS outbreak and the current COVID-19 pandemic (1) were pivotal in safeguarding the HCP involved in these procedures. 60

At our institution, a tertiary care hospital, a tracheostomy protocol was designed and 61 implemented with strict adherence and co-operation of the entire team. This study is 62 aimed at assessing incidence of COVID-19 infection among HCP involved in ST. 63 64

The key inclusion criteria were invasively ventilated adult patients managed in the 66 ICU as COVID-19 cases (CT consistent with COVID-19 and/or a positive COVID-19 67 RT-PCR test) who were referred for a ST (during the period between 26 th March 68 criteria were staff who did not consent for completing the questionnaire and HCP 70 who tested positive for COVID-19 prior to the start of the study. Emergency ST were 71 excluded from the study to reduce the potential bias of increased risk compared to a 72 planned ST. All HCP adhered to the local tracheostomy protocol(Appendix-1) and 73 personal protective equipment (PPE) guidelines. 74

A questionnaire (Appendix-2) was designed, bearing in mind the proven factors that 75 influence the potential transmission of COVID-19 among HCP (4) . The key symptoms 76 of new onset persistent cough, fever, loss of smell and/or taste as described by NHS 77

England were also included. 78

On 25 th May 2020, antibody testing against COVID-19 for NHS staff was advised by 79 NHS England. This was implemented at our institution from 1 st June 2020. After a 80 two week period (to accommodate the incubation period), on 12 th June 2020, all 81 personnel were contacted either by email or in person. A pre-formatted questionnaire 82 (Appendix-2) was given after seeking their consent for participation in the study. Two 83 further reminders were sent to non-responders; two weeks later, the survey was 84 status, complications and the outcome factors (step down, discharge or death). We 90 did not perform percutaneous tracheostomy during the COVID-19 pandemic 91 because of the increased risk of aerosolisation, need for bronchoscopy and to free 92 the critical care consultants to manage COVID-19 ICU patients.

Our first COVID-19 positive patient was admitted on 28 th Februrary 2020. The trust 95 implemented donning and doffing training along with mask fitting sessions for all 96 HCP. The first tracheostomy was performed on 26 th March 2020. England guidelines. 105

The tracheostomy protocol was drafted based on the experience of our 107 tracheostomy team and guidelines described by national and international experts (4- At the same time, it is also one of the procedures with highest risk of aerosolisation 185 with a high potential for transmission to HCP (6) . 186

The two valuable aspects that can be tailored or optimized with an aim to reduce the 187 risk of transmission include, a mandatory step-wise protocol of the procedure and an 188 appropriate level of personnel protection for the staff providing the service (4, 5) . Along 189 these lines, we adopted a tracheostomy protocol(Appendix-1) based on our In, our series, HCP exposed to 6-25 tracheostomies did not develop any key COVID- reported an increased odds ratio of 6.6 for tracheal intubation and 4.2 to 6.2 for 216 tracheostomy (6) . 217

In our report,15% of the HCP were self-isolating due to key COVID-19 symptoms. 218

None of the staff participating in the ST team needed hospitalisation or prolonged 219 time off work. During this pandemic, the nationwide NHS staff absenteeism either 220 due to self-isolation or COVID-19 related illness was around 10% for nurses and 221 6.7% for doctors (11) . 222

In a review published before the COVID-19 pandemic of 2377 patients with ARDS 223 from 50 countries (12) , 13% (309/2377) of them needed a tracheostomy during their 224 ICU stay. The median time of tracheostomy was 14 days with 75% after their first 225

week of illness. The 28-day crude mortality rate in tracheostomised patients was 226 23.4%. In our study, the overall mortality rate was 11%, none being related to ST. 227 It is agreed in general that the period of maximum infectivity is during the relatively 228 high viral load phase of COVID-19 which is around 9 to 15 days of the infection (5) . In does not translate to infectivity because the virus is rarely cultured beyond two 234 weeks, hence patients may not be infective for the full duration of viral shedding and 235 detection (13) . In yet another study, viral RNA was detected for a mean of 17 days 236 from onset of symptoms but viral cultures from PCR positive samples were rarely 237 positive beyond nine days of illness (14) . 238

Liu et al (15) , analysing the viral load in mild and serve cases of COVID-19 found that, 239

while 90% of mild cases tested RT-PCR negative at day 10 of onset of illness, all 240 patients with severe COVID-19 had a positive RT-PCR result at or beyond day 241 10.This study implied that severe COVID-19 is associated with a higher viral load 242 and a longer virus shedding period. Hence, it is prudent to exercise caution and 243 delay tracheostomy, if at all possible. In our series, the median time interval between 244 a positive test to tracheostomy was 17 days (IQR=9). 245

Wei et al, in a report of SARS illness, reported that 14-20% of SARS patients would 246 need invasive ventilation (16) . In a total of eight tracheostomies from three other case 247 series on SARS patients, no transmission to HCP was reported (16) (17) (18) . 248

In conclusion, COVID-19 will be around in the near future. Many critical care units 272 around the world will need to manage COVID-19 patients with invasive ventilation 273 and perform tracheostomies to expedite weaning and to facilitate airway 274 management. Our report highlights the safe delivery of a tracheostomy service 275 during the peak of the pandemic in England, with strict adherence to local ST 276 tracheostomy protocol and PPE use resulting in 15% staff self-isolation due to 277 suspected COVID-19 symptoms without any HCP being hospitalised. 

Safe surgical tracheostomy during the COVID-281 19 pandemic: A protocol based on experiences with Middle East Respiratory 282

Syndrome and COVID-19 outbreaks in South Korea

Pulmonary Embolism on CTPA 286 in COVID-19 Patients

Acute complications and mortality in 289 hospitalized patients with coronavirus disease 2019: a systematic review and 290 meta-analysis

Respiratory Syndrome Outbreak

Epidemiology and patterns of tracheostomy 320 practice in patients with acute respiratory distress syndrome in ICUs across 321 50 countries

SARS-CoV-2 detection, viral load and 324 infectivity over the course of an infection

Virological assessment of 328 hospitalized patients with COVID-2019

Viral dynamics in mild and severe cases of 331 COVID-19

Safe tracheostomy for patients with severe 335 acute respiratory syndrome

Tracheostomy in a patient with severe acute 338 respiratory syndrome

Elective and emergency 341 surgery in patients with severe acute respiratory syndrome (SARS)

Tracheostomy intervention in intubated 344 COVID positive patients: A survey of current clinical practice among ENT 345 surgeons

Early Data From Case Series

Tracheostomy in Patients With SARS-CoV-2

COVID-19 Patients

Referral to the tracheostomy team (surgeons and anaesthetists) who review the patient well in advance

The intensivist ensures there is no cuff leak form the endotracheal tube (ETT) and if present either changes the tube or checks the cuff is intact and optimally inflated

Availability of the appropriate tracheostomy tube and the equipment e.g. inline suction catheter mount is confirmed with the operating theatre

theatres: 1. Standard donning protocol based on guidelines issued by the trust for high aerosol generating procedures was followed

The steps of tracheostomy are reiterated to the entire theatre team giving particular importance to times of potential peak aerosol exposure, namely, 1. It is important after pre-oxygenation the ventilation is stopped momentarily to facilitate advancing the endotracheal tube just prior to the tracheotomy

Pre-oxygenation, cessation of ventilation, deflation of ETT cuff, withdrawal of the ETT under direct vision through the tracheotomy but not extubating

Insertion of the tracheostomy tube, insertion of the inner cannula, inflation of the cuff, connecting the inline catheter mount and recommencing ventilation

Tracheostomy procedure is standard as for non-covid cases but the above sequence is strictly adhered to

We thank the department of anaesthesia, intensive care unit (ICU), operation theatre nurses and practitioners, and tracheostomy surgeons who played a vital role in the overall care of the patients during the COVID-19 pandemic. We acknowledge the contributions of surgeons of Royal Free hospital and Royal National Throat, Nose

D'Souza A et al (19) , in a survey of surgeons performing tracheostomy in COVID-19 249 patients, reported a 9.7% tracheostomy rate among 3403 ventilated patients. A 250 mean of 14.4 days was noted from time of intubation to tracheostomy. Floyd et al (20) , 251 reported no sero-conversion among ten surgeons performing 38 ST in COVID-19 252 patients. Chao et al (21) reported 53 tracheostomies without transmission to HCP. The One could argue about the quality of our data based on the fact that ninety six 262 percent of the HCP included in this study were also working in other areas with 263 COVID-19 suspected or proven patients. Given the pandemic situation, it would not 264 be easy or even ethical to have a formal randomised study or have a team 265 performing or caring exclusively for tracheostomy patients. We believe that if we had 266 a dedicated ST team, their exposure to other potential sources of COVID-19 would 267 be reduced significantly and hence the group of HCP with key COVID-19 symptoms 268 would be even less than the 15% reported by us. According to the literature 269 available (5,13,19,21) , we also strongly believe that timing of tracheostomy beyond 14 270 days also had a positive impact on limiting staff infection rates.